世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Circulating Tumor Cells (CTC) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1340
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エクスビボポジティブセレクション、インビボポジティブセレクション、ネガティブセレクション、マイクロチップ・シングルスパイラルマイクロチャネル）、用途別市場規模（腫瘍形成研究、Emtバイオマーカー開発、癌幹細胞研究、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・循環腫瘍細胞（CTC）の市場動向
・企業の競争状況、市場シェア
・循環腫瘍細胞（CTC）の種類別市場規模（エクスビボポジティブセレクション、インビボポジティブセレクション、ネガティブセレクション、マイクロチップ・シングルスパイラルマイクロチャネル）
・循環腫瘍細胞（CTC）の用途別市場規模（腫瘍形成研究、Emtバイオマーカー開発、癌幹細胞研究、その他）
・循環腫瘍細胞（CTC）の北米市場規模2016-2027（アメリカ、カナダ）
・循環腫瘍細胞（CTC）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・循環腫瘍細胞（CTC）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・循環腫瘍細胞（CTC）の中南米市場規模2016-2027（メキシコ、ブラジル）
・循環腫瘍細胞（CTC）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AdnaGen、Apocell、Biocep、Canopus Bioscience、Creatv Microtech、Ikonisys、IV Diagnostics、Miltenyi Biotech、Nanostring Technologies、Rarecells Diagnostics、Vitatex）
・結論

Circulating tumor cells are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation.
Asia Pacific is expected to be the fastest growth region in circulating tumor cells market over the forecast period owing to the increasing incidences of cance.

Market Analysis and Insights: Global Circulating Tumor Cells (CTC) Market
The global Circulating Tumor Cells (CTC) market size is projected to reach US$ 4009.1 million by 2026, from US$ 1078.5 million in 2019, at a CAGR of 20.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Circulating Tumor Cells (CTC) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Circulating Tumor Cells (CTC) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Circulating Tumor Cells (CTC) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Circulating Tumor Cells (CTC) market.

Global Circulating Tumor Cells (CTC) Scope and Market Size
Circulating Tumor Cells (CTC) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells (CTC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel

Segment by Application
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ex-Vivo Positive Selection
1.2.3 In-Vivo Positive Selection
1.2.4 Negative Selection
1.2.5 Microchips & Single Spiral Micro Channel
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTC) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tumorigenesis Research
1.3.3 Emt Biomarkers Development
1.3.4 Cancer Stem Cell Research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2016-2027)
2.2 Circulating Tumor Cells (CTC) Growth Trends by Regions
2.2.1 Circulating Tumor Cells (CTC) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Circulating Tumor Cells (CTC) Historic Market Share by Regions (2016-2021)
2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Regions (2022-2027)
2.3 Circulating Tumor Cells (CTC) Industry Dynamic
2.3.1 Circulating Tumor Cells (CTC) Market Trends
2.3.2 Circulating Tumor Cells (CTC) Market Drivers
2.3.3 Circulating Tumor Cells (CTC) Market Challenges
2.3.4 Circulating Tumor Cells (CTC) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2016-2021)
3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2016-2021)
3.2 Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cells (CTC) Revenue
3.4 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2020
3.5 Circulating Tumor Cells (CTC) Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cells (CTC) Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cells (CTC) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Circulating Tumor Cells (CTC) Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2016-2021)
4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2022-2027)

5 Circulating Tumor Cells (CTC) Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2016-2021)
5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size (2016-2027)
6.2 North America Circulating Tumor Cells (CTC) Market Size by Type
6.2.1 North America Circulating Tumor Cells (CTC) Market Size by Type (2016-2021)
6.2.2 North America Circulating Tumor Cells (CTC) Market Size by Type (2022-2027)
6.2.3 North America Circulating Tumor Cells (CTC) Market Size by Type (2016-2027)
6.3 North America Circulating Tumor Cells (CTC) Market Size by Application
6.3.1 North America Circulating Tumor Cells (CTC) Market Size by Application (2016-2021)
6.3.2 North America Circulating Tumor Cells (CTC) Market Size by Application (2022-2027)
6.3.3 North America Circulating Tumor Cells (CTC) Market Size by Application (2016-2027)
6.4 North America Circulating Tumor Cells (CTC) Market Size by Country
6.4.1 North America Circulating Tumor Cells (CTC) Market Size by Country (2016-2021)
6.4.2 North America Circulating Tumor Cells (CTC) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size (2016-2027)
7.2 Europe Circulating Tumor Cells (CTC) Market Size by Type
7.2.1 Europe Circulating Tumor Cells (CTC) Market Size by Type (2016-2021)
7.2.2 Europe Circulating Tumor Cells (CTC) Market Size by Type (2022-2027)
7.2.3 Europe Circulating Tumor Cells (CTC) Market Size by Type (2016-2027)
7.3 Europe Circulating Tumor Cells (CTC) Market Size by Application
7.3.1 Europe Circulating Tumor Cells (CTC) Market Size by Application (2016-2021)
7.3.2 Europe Circulating Tumor Cells (CTC) Market Size by Application (2022-2027)
7.3.3 Europe Circulating Tumor Cells (CTC) Market Size by Application (2016-2027)
7.4 Europe Circulating Tumor Cells (CTC) Market Size by Country
7.4.1 Europe Circulating Tumor Cells (CTC) Market Size by Country (2016-2021)
7.4.2 Europe Circulating Tumor Cells (CTC) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size (2016-2027)
8.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Type
8.2.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Type (2016-2027)
8.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Application
8.3.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Application (2016-2027)
8.4 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region
8.4.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Circulating Tumor Cells (CTC) Market Size (2016-2027)
9.2 Latin America Circulating Tumor Cells (CTC) Market Size by Type
9.2.1 Latin America Circulating Tumor Cells (CTC) Market Size by Type (2016-2021)
9.2.2 Latin America Circulating Tumor Cells (CTC) Market Size by Type (2022-2027)
9.2.3 Latin America Circulating Tumor Cells (CTC) Market Size by Type (2016-2027)
9.3 Latin America Circulating Tumor Cells (CTC) Market Size by Application
9.3.1 Latin America Circulating Tumor Cells (CTC) Market Size by Application (2016-2021)
9.3.2 Latin America Circulating Tumor Cells (CTC) Market Size by Application (2022-2027)
9.3.3 Latin America Circulating Tumor Cells (CTC) Market Size by Application (2016-2027)
9.4 Latin America Circulating Tumor Cells (CTC) Market Size by Country
9.4.1 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2016-2021)
9.4.2 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size (2016-2027)
10.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Type
10.2.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Type (2016-2027)
10.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Application
10.3.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Application (2016-2027)
10.4 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country
10.4.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AdnaGen
11.1.1 AdnaGen Company Details
11.1.2 AdnaGen Business Overview
11.1.3 AdnaGen Circulating Tumor Cells (CTC) Introduction
11.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.1.5 AdnaGen Recent Development
11.2 Apocell
11.2.1 Apocell Company Details
11.2.2 Apocell Business Overview
11.2.3 Apocell Circulating Tumor Cells (CTC) Introduction
11.2.4 Apocell Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.2.5 Apocell Recent Development
11.3 Biocep
11.3.1 Biocep Company Details
11.3.2 Biocep Business Overview
11.3.3 Biocep Circulating Tumor Cells (CTC) Introduction
11.3.4 Biocep Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.3.5 Biocep Recent Development
11.4 Canopus Bioscience
11.4.1 Canopus Bioscience Company Details
11.4.2 Canopus Bioscience Business Overview
11.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Introduction
11.4.4 Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.4.5 Canopus Bioscience Recent Development
11.5 Creatv Microtech
11.5.1 Creatv Microtech Company Details
11.5.2 Creatv Microtech Business Overview
11.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Introduction
11.5.4 Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.5.5 Creatv Microtech Recent Development
11.6 Ikonisys
11.6.1 Ikonisys Company Details
11.6.2 Ikonisys Business Overview
11.6.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
11.6.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.6.5 Ikonisys Recent Development
11.7 IV Diagnostics
11.7.1 IV Diagnostics Company Details
11.7.2 IV Diagnostics Business Overview
11.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Introduction
11.7.4 IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.7.5 IV Diagnostics Recent Development
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Details
11.8.2 Miltenyi Biotech Business Overview
11.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
11.8.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.8.5 Miltenyi Biotech Recent Development
11.9 Nanostring Technologies
11.9.1 Nanostring Technologies Company Details
11.9.2 Nanostring Technologies Business Overview
11.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Introduction
11.9.4 Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.9.5 Nanostring Technologies Recent Development
11.10 Rarecells Diagnostics
11.10.1 Rarecells Diagnostics Company Details
11.10.2 Rarecells Diagnostics Business Overview
11.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Introduction
11.10.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.10.5 Rarecells Diagnostics Recent Development
11.11 Vitatex
11.11.1 Vitatex Company Details
11.11.2 Vitatex Business Overview
11.11.3 Vitatex Circulating Tumor Cells (CTC) Introduction
11.11.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2016-2021)
11.11.5 Vitatex Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ex-Vivo Positive Selection
Table 3. Key Players of In-Vivo Positive Selection
Table 4. Key Players of Negative Selection
Table 5. Key Players of Microchips & Single Spiral Micro Channel
Table 6. Global Circulating Tumor Cells (CTC) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Circulating Tumor Cells (CTC) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Circulating Tumor Cells (CTC) Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Circulating Tumor Cells (CTC) Market Share by Regions (2016-2021)
Table 10. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Circulating Tumor Cells (CTC) Market Share by Regions (2022-2027)
Table 12. Circulating Tumor Cells (CTC) Market Trends
Table 13. Circulating Tumor Cells (CTC) Market Drivers
Table 14. Circulating Tumor Cells (CTC) Market Challenges
Table 15. Circulating Tumor Cells (CTC) Market Restraints
Table 16. Global Circulating Tumor Cells (CTC) Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Circulating Tumor Cells (CTC) Market Share by Players (2016-2021)
Table 18. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells (CTC) as of 2020)
Table 19. Ranking of Global Top Circulating Tumor Cells (CTC) Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTC) Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Circulating Tumor Cells (CTC) Product Solution and Service
Table 23. Date of Enter into Circulating Tumor Cells (CTC) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Circulating Tumor Cells (CTC) Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2016-2021)
Table 27. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Circulating Tumor Cells (CTC) Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2016-2021)
Table 31. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Circulating Tumor Cells (CTC) Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Circulating Tumor Cells (CTC) Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Circulating Tumor Cells (CTC) Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Circulating Tumor Cells (CTC) Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Circulating Tumor Cells (CTC) Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Circulating Tumor Cells (CTC) Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Circulating Tumor Cells (CTC) Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Circulating Tumor Cells (CTC) Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Circulating Tumor Cells (CTC) Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Circulating Tumor Cells (CTC) Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Circulating Tumor Cells (CTC) Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Circulating Tumor Cells (CTC) Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Circulating Tumor Cells (CTC) Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Circulating Tumor Cells (CTC) Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Circulating Tumor Cells (CTC) Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Circulating Tumor Cells (CTC) Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2022-2027) & (US$ Million)
Table 63. AdnaGen Company Details
Table 64. AdnaGen Business Overview
Table 65. AdnaGen Circulating Tumor Cells (CTC) Product
Table 66. AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 67. AdnaGen Recent Development
Table 68. Apocell Company Details
Table 69. Apocell Business Overview
Table 70. Apocell Circulating Tumor Cells (CTC) Product
Table 71. Apocell Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 72. Apocell Recent Development
Table 73. Biocep Company Details
Table 74. Biocep Business Overview
Table 75. Biocep Circulating Tumor Cells (CTC) Product
Table 76. Biocep Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 77. Biocep Recent Development
Table 78. Canopus Bioscience Company Details
Table 79. Canopus Bioscience Business Overview
Table 80. Canopus Bioscience Circulating Tumor Cells (CTC) Product
Table 81. Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 82. Canopus Bioscience Recent Development
Table 83. Creatv Microtech Company Details
Table 84. Creatv Microtech Business Overview
Table 85. Creatv Microtech Circulating Tumor Cells (CTC) Product
Table 86. Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 87. Creatv Microtech Recent Development
Table 88. Ikonisys Company Details
Table 89. Ikonisys Business Overview
Table 90. Ikonisys Circulating Tumor Cells (CTC) Product
Table 91. Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 92. Ikonisys Recent Development
Table 93. IV Diagnostics Company Details
Table 94. IV Diagnostics Business Overview
Table 95. IV Diagnostics Circulating Tumor Cells (CTC) Product
Table 96. IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 97. IV Diagnostics Recent Development
Table 98. Miltenyi Biotech Company Details
Table 99. Miltenyi Biotech Business Overview
Table 100. Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 101. Miltenyi Biotech Recent Development
Table 102. Nanostring Technologies Company Details
Table 103. Nanostring Technologies Business Overview
Table 104. Nanostring Technologies Circulating Tumor Cells (CTC) Product
Table 105. Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 106. Nanostring Technologies Recent Development
Table 107. Rarecells Diagnostics Company Details
Table 108. Rarecells Diagnostics Business Overview
Table 109. Rarecells Diagnostics Circulating Tumor Cells (CTC) Product
Table 110. Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 111. Rarecells Diagnostics Recent Development
Table 112. Vitatex Company Details
Table 113. Vitatex Business Overview
Table 114. Vitatex Circulating Tumor Cells (CTC) Product
Table 115. Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2016-2021) & (US$ Million)
Table 116. Vitatex Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cells (CTC) Market Share by Type: 2020 VS 2027
Figure 2. Ex-Vivo Positive Selection Features
Figure 3. In-Vivo Positive Selection Features
Figure 4. Negative Selection Features
Figure 5. Microchips & Single Spiral Micro Channel Features
Figure 6. Global Circulating Tumor Cells (CTC) Market Share by Application: 2020 VS 2027
Figure 7. Tumorigenesis Research Case Studies
Figure 8. Emt Biomarkers Development Case Studies
Figure 9. Cancer Stem Cell Research Case Studies
Figure 10. Others Case Studies
Figure 11. Circulating Tumor Cells (CTC) Report Years Considered
Figure 12. Global Circulating Tumor Cells (CTC) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Circulating Tumor Cells (CTC) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Circulating Tumor Cells (CTC) Market Share by Regions: 2020 VS 2027
Figure 15. Global Circulating Tumor Cells (CTC) Market Share by Regions (2022-2027)
Figure 16. Global Circulating Tumor Cells (CTC) Market Share by Players in 2020
Figure 17. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells (CTC) as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTC) Revenue in 2020
Figure 19. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2016-2021)
Figure 20. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2022-2027)
Figure 21. North America Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Circulating Tumor Cells (CTC) Market Share by Type (2016-2027)
Figure 23. North America Circulating Tumor Cells (CTC) Market Share by Application (2016-2027)
Figure 24. North America Circulating Tumor Cells (CTC) Market Share by Country (2016-2027)
Figure 25. United States Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Circulating Tumor Cells (CTC) Market Share by Type (2016-2027)
Figure 29. Europe Circulating Tumor Cells (CTC) Market Share by Application (2016-2027)
Figure 30. Europe Circulating Tumor Cells (CTC) Market Share by Country (2016-2027)
Figure 31. Germany Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Region (2016-2027)
Figure 41. China Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Circulating Tumor Cells (CTC) Market Share by Type (2016-2027)
Figure 49. Latin America Circulating Tumor Cells (CTC) Market Share by Application (2016-2027)
Figure 50. Latin America Circulating Tumor Cells (CTC) Market Share by Country (2016-2027)
Figure 51. Mexico Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Country (2016-2027)
Figure 57. Turkey Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Circulating Tumor Cells (CTC) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AdnaGen Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 61. Apocell Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 62. Biocep Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 63. Canopus Bioscience Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 64. Creatv Microtech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 65. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 66. IV Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 67. Miltenyi Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 68. Nanostring Technologies Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 69. Rarecells Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 70. Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Global Circulating Tumor Cells and Cancer Stem Cells Market Size, Status and Forecast 2021-2027
QYR2104Z1342 2021年4月 95Pages
QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）・がん幹細胞（CSC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞濃縮、検出、CTC分析）、用途別市場規模（病院、NSC、医学研究機関）、主要地域別市場規模（北米、アメリ...

世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年）

Global Circulating Tumor Cells Market Size, Status and Forecast 2021-2027
QYR2104Z1343 2021年4月 129Pages
QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CTC濃縮、CTC検出、CTC分析）、用途別市場規模（乳がん、前立腺がん、大腸がん、肺がん、その他）、主要地域別市場規模（北米、ア...

世界の循環腫瘍細胞（CTC）予後技術市場規模・現状・予測（2021年-2027年）

Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, Status and Forecast 2021-2027
QYR2104Z1341 2021年4月 99Pages
QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）予後技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍細胞濃縮、腫瘍細胞検出）、用途別市場規模（前立腺がん、乳がん、結腸直腸がん、肺がん、卵巣がん、膵臓がん）、主要地域別市...

世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年）

Global Circulating Tumor Cell Market Size, Status and Forecast 2021-2027
QYR2104Z1339 2021年4月 131Pages
QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CTC濃縮、CTC検出、CTC分析）、用途別市場規模（乳がん、前立腺がん、大腸がん、その他）、主要地域別市場規模（北米、アメリカ、...

世界の循環腫瘍細胞（CTC）診断市場規模・現状・予測（2021年-2027年）

Global Circulating Tumor Cell (CTC) Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z1337 2021年4月 130Pages
QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CTC濃縮、CTC検出）、用途別市場規模（病院・クリニック、製薬・バイオテクノロジー企業、学術研究機関、CRO）、主要地域別市...

世界の循環腫瘍細胞（CTC）診断市場規模・現状・予測（2021年-2027年）

Global Circulating Tumor Cell Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z1338 2021年4月 133Pages
QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CTC濃縮、CTC検出、CTC分析）、用途別市場規模（腫瘍形成研究、EMTバイオマーカー開発、がん幹細胞研究、その他）、主要地...

世界のリキッドバイオプシー用循環バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Circulating Biomarker for Liquid Biopsy Market Size, Status and Forecast 2021-2027
QYR2104Z1336 2021年4月 95Pages
QYResearch社発行の本調査資料では、リキッドバイオプシー用循環バイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、無細胞DNA（cfDNA）、細胞外小胞（EV）、その他）、...

世界の微生物燃料電池（MFC）市場規模・現状・予測（2021年-2027年）

Global Microbial Fuel Cells (MFC) Market Size, Status and Forecast 2021-2027
QYR2104Z3752 2021年4月 99Pages
QYResearch社発行の本調査資料では、微生物燃料電池（MFC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（仲介MFC、非仲介MFC）、用途別市場規模（農業、医療、食品・飲料、政府・都市用、その他）、主要地域別市場規模（北米、アメリカ、...

世界のがん幹細胞（CSC）市場規模・現状・予測（2021年-2027年）

Global Cancer Stem Cells Market Size, Status and Forecast 2021-2027
QYR2104Z1072 2021年4月 92Pages
QYResearch社発行の本調査資料では、がん幹細胞（CSC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞培養、細胞分離、細胞分析、分子分析、その他）、用途別市場規模（乳がん診断・治療、前立腺がん診断・治療、結腸直腸がん診断・治療、肺...

世界の腫瘍治療フィールド市場規模・現状・予測（2021年-2027年）

Global Tumor Treating Fields (TTFields) Market Size, Status and Forecast 2021-2027
QYR2104Z5761 2021年4月 94Pages
QYResearch社発行の本調査資料では、腫瘍治療フィールドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（低周波、中周波）、用途別市場規模（病院、診療所、がん・放射線治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
世界の循環腫瘍細胞（CTC）予後技術市場規模・現状・予測（2021年-2027年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年） Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…
世界の循環腫瘍細胞（CTC）診断市場規模・現状・予測（2021年-2027年） Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various tumor markers that can be used along with companion diagnostics to diagnose or monitor various forms of cancer…
世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年） Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…